Connection

Yongxia Wu to Mice

This is a "connection" page, showing publications Yongxia Wu has written about Mice.
Connection Strength

0.657
  1. MicroRNA-31 regulates T-cell metabolism via HIF1a and promotes chronic GVHD pathogenesis in mice. Blood Adv. 2022 05 24; 6(10):3036-3052.
    View in: PubMed
    Score: 0.091
  2. STING negatively regulates allogeneic T-cell responses by constraining antigen-presenting cell function. Cell Mol Immunol. 2021 03; 18(3):632-643.
    View in: PubMed
    Score: 0.083
  3. Modelling CAR-T therapy in humanized mice. EBioMedicine. 2019 Feb; 40:25-26.
    View in: PubMed
    Score: 0.072
  4. MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice. Blood. 2018 04 26; 131(17):1974-1986.
    View in: PubMed
    Score: 0.068
  5. MicroRNA-17-92 controls T-cell responses in graft-versus-host disease and leukemia relapse in mice. Blood. 2015 Sep 10; 126(11):1314-23.
    View in: PubMed
    Score: 0.056
  6. The Absence of IL-12R?2 Expression on Recipient Nonhematopoietic Cells Diminishes Acute Graft-versus-Host Disease in the Gastrointestinal Tract. J Immunol. 2023 02 15; 210(4):486-495.
    View in: PubMed
    Score: 0.024
  7. The splanchnic mesenchyme is the tissue of origin for pancreatic fibroblasts during homeostasis and tumorigenesis. Nat Commun. 2023 01 03; 14(1):1.
    View in: PubMed
    Score: 0.024
  8. Variation in blood microbial lipopolysaccharide (LPS) contributes to immune reconstitution in response to suppressive antiretroviral therapy in HIV. EBioMedicine. 2022 Jun; 80:104037.
    View in: PubMed
    Score: 0.023
  9. Chronic cannabis smoking-enriched oral pathobiont drives behavioral changes, macrophage infiltration, and increases ?-amyloid protein production in the brain. EBioMedicine. 2021 Dec; 74:103701.
    View in: PubMed
    Score: 0.022
  10. XBP-1s Promotes B Cell Pathogenicity in Chronic GVHD by Restraining the Activity of Regulated IRE-1a-Dependent Decay. Front Immunol. 2021; 12:705484.
    View in: PubMed
    Score: 0.022
  11. Nuclear PFKP promotes CXCR4-dependent infiltration by T cell acute lymphoblastic leukemia. J Clin Invest. 2021 08 16; 131(16).
    View in: PubMed
    Score: 0.022
  12. Interleukin-23 receptor signaling by interleukin-39 potentiates T cell pathogenicity in acute graft-versus-host disease. Am J Transplant. 2021 11; 21(11):3538-3549.
    View in: PubMed
    Score: 0.021
  13. A single strain of Bacteroides fragilis protects gut integrity and reduces GVHD. JCI Insight. 2021 02 08; 6(3).
    View in: PubMed
    Score: 0.021
  14. Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity while Preventing Graft Versus Host Disease. Clin Cancer Res. 2020 07 01; 26(13):3481-3490.
    View in: PubMed
    Score: 0.019
  15. Systemic translocation of Staphylococcus drives autoantibody production in HIV disease. Microbiome. 2019 02 14; 7(1):25.
    View in: PubMed
    Score: 0.018
  16. Inhibition of the IRE-1a/XBP-1 pathway prevents chronic GVHD and preserves the GVL effect in mice. Blood Adv. 2018 02 27; 2(4):414-427.
    View in: PubMed
    Score: 0.017
  17. T-bet Promotes Acute Graft-versus-Host Disease by Regulating Recipient Hematopoietic Cells in Mice. J Immunol. 2016 Apr 01; 196(7):3168-79.
    View in: PubMed
    Score: 0.015
  18. Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice. PLoS One. 2015; 10(9):e0137641.
    View in: PubMed
    Score: 0.014
  19. Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice. Biol Blood Marrow Transplant. 2015 Jul; 21(7):1195-204.
    View in: PubMed
    Score: 0.014
  20. T-bet is critical for the development of acute graft-versus-host disease through controlling T cell differentiation and function. J Immunol. 2015 Jan 01; 194(1):388-97.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.